Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery Cyclin E1
Path
Created with Sketch.
Go to Cyclin E1 Normal Tissue Gallery
Go back to Product Page
Breast – Invasive breast cancer of no special type (NST) with faint Cyclin E1 immunostaining of few tumor cells
Breast – Invasive breast cancer of no special type (NST) with faint Cyclin E1 immunostaining of few tumor cells
Colon – Colorectal adenocarcinoma with moderate Cyclin E1 positivity of most tumor cells
Colon – Colorectal adenocarcinoma with moderate Cyclin E1 positivity of most tumor cells
Colon – Colorectal adenocarcinoma with mucinous features and a moderate to strong Cyclin E1 staining of only very few tumor cells
Colon – Colorectal adenocarcinoma with mucinous features and a moderate to strong Cyclin E1 staining of only very few tumor cells
Esophagus – Adenocarcinoma (signet cell type) with strong Cyclin E1 staining of most tumor cells
Esophagus – Adenocarcinoma (signet cell type) with strong Cyclin E1 staining of most tumor cells
Esophagus – Adenocarcinoma with strong Cyclin E1 staining of most tumor cells
Esophagus – Adenocarcinoma with strong Cyclin E1 staining of most tumor cells
Esophagus – Squamous cell carcinoma with weak to moderate Cyclin E1 staining of tumor cells
Esophagus – Squamous cell carcinoma with weak to moderate Cyclin E1 staining of tumor cells
Kidney – Clear cell renal cell carcinoma showing a moderate Cyclin E1 staining of only very few tumor cells
Kidney – Clear cell renal cell carcinoma showing a moderate Cyclin E1 staining of only very few tumor cells
Kidney – Cyclin E1 negative clear cell carcinoma
Kidney – Cyclin E1 negative clear cell carcinoma
Kidney – Oncocytoma with moderate Cyclin E1 staining of few tumor cells
Kidney – Oncocytoma with moderate Cyclin E1 staining of few tumor cells
Kidney – Papillary renal cell carcinoma with a moderate Cyclin E1 staining of only few tumor cells
Kidney – Papillary renal cell carcinoma with a moderate Cyclin E1 staining of only few tumor cells
Oral cavity – Squamous cell carcinoma showing a moderate to strong Cyclin E1 immunostaining of most tumor cells
Oral cavity – Squamous cell carcinoma showing a moderate to strong Cyclin E1 immunostaining of most tumor cells
Oral cavity – Squamous cell carcinoma with faint Cyclin E1 staining of few tumor cells
Oral cavity – Squamous cell carcinoma with faint Cyclin E1 staining of few tumor cells
Ovary – Clear cell carcinoma with strong Cyclin E1 staining of all tumor cells
Ovary – Clear cell carcinoma with strong Cyclin E1 staining of all tumor cells
Ovary – Endometroid carcinoma with strong Cyclin E1 positivity of most tumor cells
Ovary – Endometroid carcinoma with strong Cyclin E1 positivity of most tumor cells
Ovary – Serous high-grade carcinoma showing a moderate to strong Cyclin E1 staining of most tumor cells
Ovary – Serous high-grade carcinoma showing a moderate to strong Cyclin E1 staining of most tumor cells
Pharynx – Squamous cell carcinoma with a weak to moderate Cyclin E1 staining of a subset of tumor cells
Pharynx – Squamous cell carcinoma with a weak to moderate Cyclin E1 staining of a subset of tumor cells
Prostate – Adenocarcinoma (Gleason 3+3=6) showing a weak Cyclin E1 positivity of a small fraction of tumor cells
Prostate – Adenocarcinoma (Gleason 3+3=6) showing a weak Cyclin E1 positivity of a small fraction of tumor cells
Prostate – Cyclin E1 negative adenocarcinoma (Gleason 3+3=6)
Prostate – Cyclin E1 negative adenocarcinoma (Gleason 3+3=6)
Thyroid – Papillary cancer with a weak to moderate Cyclin E1 immunostaining of a fraction of tumor cells
Thyroid – Papillary cancer with a weak to moderate Cyclin E1 immunostaining of a fraction of tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma (pT2-4) with a moderate to strong Cyclin E1 positivity of a large fraction of tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma (pT2-4) with a moderate to strong Cyclin E1 positivity of a large fraction of tumor cells
Urinary bladder – Non-invasive urothelial carcinoma (low grade, pTaG2) with a low to moderate Cyclin E1 staining of tumor cells
Urinary bladder – Non-invasive urothelial carcinoma (low grade, pTaG2) with a low to moderate Cyclin E1 staining of tumor cells
Urinary bladder – Non-invasive urothelial carcinoma (low grade, pTaG2) with faint Cyclin E1 staining of few tumor cells
Urinary bladder – Non-invasive urothelial carcinoma (low grade, pTaG2) with faint Cyclin E1 staining of few tumor cells